Indiana Attorney General Todd Rokita said the dealer sold cars online in a way that led consumers to believe the seller was a private owner. For its part, the dealer said it was a one-time occurrence.
Anthem paying $594M to settle antitrust litigation, but deal terms might fuel growth
Paying a half-billion-dollar settlement might seem painful, but health care observers say resulting changes to Blue Cross Blue Shield rules are so favorable to Anthem’s growth prospects that the deal is a huge win.Read More
Anthem agrees to pay $39.5M in latest settlement over 2015 hacking
Anthem said the settlement closes the last investigation into the hacking, which exposed personal information of nearly 79 million customers.Read More
Former ITT Tech students in Indiana to get $10M in debt relief
More than 1,300 students who were enrolled at now-closed ITT Technical Institute campuses in Indiana are eligible for student loan forgiveness as part of a $330 million national settlement affecting as many as 35,000 former ITT students.Read More
Four companies that agreed to pay a combined $26 billion to settle claims about their roles in the opioid crisis plan to deduct some of those costs from their taxes and recoup around $1 billion apiece.
The global business consulting firm McKinsey & Company has agreed to a $573 million settlement with 49 states over its role in advising companies on how to “supercharge” opioid sales amid an overdose crisis.
The chemicals at issue are known as per- and polyfluoroalkyl substances, or PFAS. They include perfluorooctanoic acid, which was used in the production of Teflon, firefighting foam, water-repellent clothing and many other household and personal items.
Policyholders allege Conseco and its parent companies, Carmel-based CNO Financial Group Inc. and CNO Services LLC, overcharged policyholders through improper premiums and cost of insurance charges.
Purdue Pharma, the company that makes OxyContin, the powerful painkiller that experts say helped touch off an opioid epidemic, will plead guilty to counts including conspiracy to defraud the United States and violating federal anti-kickback laws, the officials said.
The pharmaceutical company said the Roundup settlement would “bring closure to approximately 75%” of the current 125,000 claims against subsidiary Monsanto.
Former Colts quarterback Art Schlichter has received nearly $700,000 from a national settlement with the NFL over concussions. A prosecutor says that money should go to Schlichter’s many fraud victims.
Indiana was one of only two states that did not participate in a multistate settlement in July 2019 that distributed $175 million in total to 48 states.
Indianapolis-based USA Gymnastics has filed a bankruptcy plan that includes an offer of $215 million in insurance funds for sexual abuse victims to settle their claims against the embattled organization.
The fine settles U.S. Securities and Exchange Commission charges that the Indianapolis-based fuel-products refiner issued inaccurate information about its 2017 financial performance.
With the release of the feature film “Dark Waters” on Tuesday, the law firm Taft Stettinius & Hollister, which has offices in Indianapolis and eight other cities, is about to get the kind of publicity that money can’t buy.
Johnson & Johnson has agreed to a $117 million multistate settlement over allegations it deceptively marketed its pelvic mesh products, which support women’s sagging pelvic organs.
Outlines of a settlement call for $22 billion in cash over time plus up to $15 billion worth of overdose antidotes and treatment drugs, with distribution of those drugs valued at another $14 billion.
The company says it did nothing wrong but decided to settle the case, which involved allegations of discrimination against female applicants at its Shelbyville warehouse.
Indiana Attorney General Curtis Hill is among the 29 attorneys general across the country backing a proposed settlement with OxyContin maker Purdue Pharma, calling the agreement a “significant breakthrough in our important fight against the opioid crisis.”
Purdue Pharma may have just set the starting point for determining what it will cost dozens of pharmaceutical companies to resolve legal liability over their role in creating the U.S. opioid epidemic.
By Thursday, half of the nation’s state attorneys general said they would reject a tentative deal crafted by the other half, and many criticized the terms as grossly insufficient.
A tentative settlement announced Wednesday over the role Purdue Pharma played in the nation’s opioid addiction crisis falls short of the far-reaching national settlement the OxyContin maker had been seeking for months, with litigation sure to continue.
An agreement would ease investor pressure over massive litigation exposure the German drug and chemical giant took on with its $63 billion purchase of the weedkiller’s maker, Monsanto Co.